About this trial
The study aims to evaluate the effectiveness of intraoperative combination of ketamine and magnesium sulfate infusions on postoperative analgesia in patients undergoing open rhinoplasty.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age from 18 to 65 years.
Both sexes.
American Society of Anesthesiologists (ASA) physical status I - II.
Scheduled for rhinoplasty under general anesthesia.
Disqualifiers
Receiving analgesic or any medications since 48 hours before the surgery.
Drug addiction.
Cardiovascular disease.
Respiratory disease, renal, liver, metabolic and neurological disease.
Trial design
Parallel
Treatments tested in this trial
Ketamine and Magnesium Sulfate
DrugPatients will receive a bolus of 0.5 mg/kg of ketamine given over a period of ten minutes followed by a constant infusion of 0.25 mg/kg/hr and a bolus dose of 30 mg/kg of magnesium sulfate during a 10-minute period followed by a continuous infusion of 9 mg/kg/hr.
Saline 0.9%
DrugPatients will receive saline 0.9% as a control group.
Treatment groups
Trial outcomes
Primary outcomes
Total morphine consumption
Rescue analgesia of morphine will be given as a 3 mg bolus if the numeric rating scale (NRS) \> 3, to be repeated after 30 min if pain persists until the NRS \< 4.
Secondary outcomes
Time to the 1st rescue analgesia.
Time to the first request for the rescue analgesia (time from end of surgery to first dose of morphine administrated).
Degree of pain
Each patient will be instructed about postoperative pain assessment with the numeric rating scale (NRS). NRS (0 represents "no pain" while 10 represents "the worst pain imaginable"). NRS will be assessed at 0, 4, 6, 8, 12, 18, and 24 h postoperatively.
Heart rate
Heart rate will be recorded preoperatively and every 15 minutes till the end of surgery.
Mean arterial pressure
Mean arterial pressure will be recorded preoperatively and every 15 minutes till the end of surgery.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.